VDAC1 SILENCING MOLECULES AND USE THEREOF

Varda Shoshan-Barmatz

VDAC1 SILENCING MOLECULES AND USE THEREOF

Department of Life Sciences

Research output: Patent

Abstract

The present invention relates to the field of cancer therapy, specifically to potent RNA inhibitory molecules silencing the expression of Voltage-Dependent Ion Chanel- (VDAC1) and to the use of RNA inhibitory molecules for treating cancer.

Original language	English
Patent number	WO2020089906
IPC	A61P 35/ 00 A I
Priority date	27/06/19
State	Published - 7 May 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{8c3658d63a6c408794dde297518cd097,

title = "VDAC1 SILENCING MOLECULES AND USE THEREOF",

abstract = "The present invention relates to the field of cancer therapy, specifically to potent RNA inhibitory molecules silencing the expression of Voltage-Dependent Ion Chanel- (VDAC1) and to the use of RNA inhibitory molecules for treating cancer.",

author = "Varda Shoshan-Barmatz",

year = "2020",

month = may,

day = "7",

language = "English",

type = "Patent",

note = "WO2020089906; A61P 35/ 00 A I",

}

TY - PAT

T1 - VDAC1 SILENCING MOLECULES AND USE THEREOF

AU - Shoshan-Barmatz, Varda

PY - 2020/5/7

Y1 - 2020/5/7

N2 - The present invention relates to the field of cancer therapy, specifically to potent RNA inhibitory molecules silencing the expression of Voltage-Dependent Ion Chanel- (VDAC1) and to the use of RNA inhibitory molecules for treating cancer.

AB - The present invention relates to the field of cancer therapy, specifically to potent RNA inhibitory molecules silencing the expression of Voltage-Dependent Ion Chanel- (VDAC1) and to the use of RNA inhibitory molecules for treating cancer.

M3 - Patent

M1 - WO2020089906

ER -

VDAC1 SILENCING MOLECULES AND USE THEREOF

Abstract

UN SDGs

Fingerprint

Cite this